Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Agreement Between Accelerometric and Acoustic Signals Utilizing Algorithm and Body Plethysmograph in Detecting Nasal and Oral Specific Airway Resistance

NCT05869071 is registered in ClinicalTrials.gov with Oulu University Hospital as lead sponsor.

NCT NCT05869071
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05869071 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Agreement Between Accelerometric and Acoustic Signals Utilizing Algorithm and Body Plethysmograph in Detecting Nasal and Oral Specific Airway Resistance
Lead sponsor
Oulu University Hospital
Phase
Observational
Overall status
Unknown status
Start date
May 23, 2023
Completion date
June 30, 2024
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

allergic rhinitis, asthma, copd, nasal polyps